Grantham, Mayo, Van Otterloo & Co (GMO)’s Scansource SCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,053
Closed -$386K 672
2023
Q2
$386K Hold
13,053
﹤0.01% 586
2023
Q1
$397K Sell
13,053
-2,300
-15% -$71.5K ﹤0.01% 586
2022
Q4
$449K Sell
15,353
-700
-4% -$20.8K ﹤0.01% 597
2022
Q3
$424K Sell
16,053
-19,700
-55% -$595K ﹤0.01% 591
2022
Q2
$1.11M Hold
35,753
0.01% 507
2022
Q1
$1.24M Buy
35,753
+21,600
+153% +$714K 0.01% 503
2021
Q4
$496K Hold
14,153
﹤0.01% 601
2021
Q3
$492K Buy
14,153
+3,900
+38% +$120K ﹤0.01% 597
2021
Q2
$288K Buy
+10,253
New +$305K ﹤0.01% 668
2019
Q4
Sell
-13,100
Closed -$400K 757
2019
Q3
$400K Sell
13,100
-10,200
-44% -$317K ﹤0.01% 647
2019
Q2
$759K Buy
+23,300
New +$792K 0.01% 560

Other funds holding SCSC

Grantham, Mayo, Van Otterloo & Co (GMO)'s SCSC Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Scansource (SCSC) in Q3 2023, closing a stake of 13,053 shares — an estimated $386K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SCSC in Q2 2019 and held it in 11 quarters. The position peaked at $1.24M in Q1 2022. 162 funds tracked by Wall St. Rank hold SCSC as of Q3 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Scansource position as of Q3 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 13,053 Scansource shares in Q3 2023, an estimated $386K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Scansource in Q2 2019 and held it in 11 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Scansource position peaked at $1.24M in Q1 2022.
  • 162 funds tracked by Wall St. Rank held Scansource as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.